Myriad Venture Partners, an early-stage venture capital firm, has significantly expanded its Executive Advisory Board, now comprising over 30 senior leaders from global enterprises. The new members hail from industry giants such as GSK, Mastercard, Oracle, and Harley-Davidson. This strategic enhancement aims to deepen the firm's hands-on support for startups in enterprise AI and B2B software.
A Strategic Expansion of Expertise
The board welcomes a distinguished group of C-suite executives, including Greg Ulrich, Chief AI & Data Officer at Mastercard, and Dan Roth, Chief AI Scientist of Oracle. Other notable additions are Kim Branson, Global Head of AI & Machine Learning at GSK, and Raj Velmurugan, CIO at Harley-Davidson. This influx of talent brings deep operational experience from diverse sectors like finance, technology, and professional services.
Chris Fisher, Founder and Managing Partner of Myriad, emphasized the board's unique role, stating it is an extension of the firm's operating model. He noted that these executives have led critical technology and go-to-market functions within the world's largest companies. Their direct involvement helps founders align their products with enterprise needs from the very beginning.
An Integrated Operational Model
Unlike traditional advisory groups, Myriad's board members are deeply integrated into the firm's core activities. They actively participate in sourcing new investments, conducting technical diligence, and providing crucial product feedback. This direct engagement ensures that portfolio companies receive practical, actionable guidance throughout their growth journey.
This collaborative model creates a symbiotic relationship between startups and established corporations. Founders gain invaluable insights and commercial introductions, accelerating their path to market deployment and scalability. Meanwhile, corporate partners get early visibility into disruptive technologies that are defining the future of enterprise software and AI.
Measurable Impact and Portfolio Growth
The effectiveness of Myriad's enterprise network is demonstrated by impressive growth metrics since its inception. The firm has facilitated over 900 commercial introductions between its startups and large enterprises. These connections have led to 70 proof-of-concept engagements and resulted in 24 commercial contracts for its portfolio companies.
This support has translated into significant market traction and financial success for the startups Myriad backs. Technology developed by its portfolio companies is now used by 119 Fortune 500 companies. Collectively, these startups have raised over $932 million in funding, with $223 million secured in 2025 alone.
Recent investments underscore the firm's focus on transformative technologies, including CVector's $5 million seed round for its industrial AI platform. Another example is OpenHands' $18.8 million Series A to advance its secure cloud agent platform. Furthermore, portfolio company Patlytics, an AI-powered patent management tool, was recently highlighted as a potential future unicorn.
The expansion of its Executive Advisory Board solidifies Myriad Venture Partners' distinctive position within the venture capital ecosystem. By embedding seasoned enterprise leaders into its operational fabric, the firm accelerates innovation and commercial success for its portfolio companies. This strategic move reinforces Myriad's commitment to bridging the gap between emerging technology and global industry needs.